Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MEETINGS - Technology Acquisition: The Impact of Clinical Trials (US) October 1998:

This article was originally published in Clinica

Executive Summary

The Association for the Advancement of Medical Instrumentation will hold a meeting entitled Technology Acquisition: The Impact of Clinical Trials on October 9-10 in Baltimore. Representatives from the Health Care Financing Administration, the FDA and industry will discuss topics such as requirements for clinical trial design and outcomes; interpretation of safety and effectiveness in premarket approval process; and new guidelines for premarket approval of Class III devices by means of a product development protocol. The government's views on technology assessment and clinical trials will also be presented. Delegates will be able to participate in a mock clinical trial developed by the FDA to train its reviewers. For more information contact AAMI in the US. Fax: +1 703 525 1424.

You may also be interested in...



Execs On The Move: New R&D Chief Promotion At HAL Allergy; Two C-Level Appointments At Starkey

HAL Allergy Group, developer of products for allergy diagnostics and allergen immunotherapy, promoted its principal scientist to chief R&D officer; Starkey Hearing Technologies brought on new health and business development execs to expand its global footprint; and more.

Interview: Novartis's Big Hopes For Beovu

After a strong start in the US, Novartis is now ready to take on Bayer's wet age-related macular degeneration blockbuster Eylea in Europe.

Flu Vaccine Leader Sanofi Joins Fight Against COVID-19

As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.

Topics

UsernamePublicRestriction

Register

MT082959

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel